{"id":494915,"date":"2026-01-05T21:04:11","date_gmt":"2026-01-05T21:04:11","guid":{"rendered":"https:\/\/www.europesays.com\/us\/494915\/"},"modified":"2026-01-05T21:04:11","modified_gmt":"2026-01-05T21:04:11","slug":"weight-loss-drug-now-more-affordable-available-in-pill-form","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/494915\/","title":{"rendered":"Weight-loss drug now more affordable, available in pill form"},"content":{"rendered":"<p class=\"text | article-text\">(CNN) \u2013 Drugmaker Novo Nordisk announced Monday it is making its weight-loss drug Wegovy available as a pill for less than $150 a month. <\/p>\n<p class=\"text | article-text\">The program is for the starter dose of the popular drug. <\/p>\n<p class=\"text | article-text\">It\u2019s an option for people who don\u2019t want to do a weekly injection.<\/p>\n<p><img decoding=\"async\" class=\"figure-img img-fluid mx-auto d-block\" alt=\"Image of 1.5 mg starter dose of Wegovy\u00ae pill (PRNewsfoto\/NOVO NORDISK INC.)\" loading=\"lazy\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2026\/01\/IOF5ERUAGRBRNAHXGXW2LUOA44.jpg\" width=\"980\" height=\"551\" \/>Image of 1.5 mg starter dose of Wegovy\u00ae pill (PRNewsfoto\/NOVO NORDISK INC.)(Hand-out | NOVO NORDISK INC.)<\/p>\n<p class=\"text | article-text\">Novo Nordisk said higher doses will also be available in pill form, at different price points, by the end of the week. <\/p>\n<p class=\"text | article-text\">The new starter-dose deal is for patients who can pay cash. It was set up through an agreement the company made with the Trump administration. <\/p>\n<p class=\"copyright |\">Copyright 2026 CNN Newsource. All rights reserved.<\/p>\n","protected":false},"excerpt":{"rendered":"(CNN) \u2013 Drugmaker Novo Nordisk announced Monday it is making its weight-loss drug Wegovy available as a pill&hellip;\n","protected":false},"author":3,"featured_media":494916,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[222751,210,1060,9412,15209,4352,67,132,68,2402,15206,222752],"class_list":{"0":"post-494915","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-gpl-1","9":"tag-health","10":"tag-medication","11":"tag-novo-nordisk","12":"tag-semaglutide","13":"tag-trump-administration","14":"tag-united-states","15":"tag-unitedstates","16":"tag-us","17":"tag-wegovy","18":"tag-weight-loss-drugs","19":"tag-weightloss-pills"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115844524615786728","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/494915","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=494915"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/494915\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/494916"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=494915"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=494915"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=494915"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}